Eli Lilly and Company News - June 25, 2026

🟢 LLY is trading 2.2% up today after a $1.9B Abbisko deal and China obesity drug optimism

LLY is trading 2.2% up at $1141.61 following news of a potential $1.9 billion research collaboration with Abbisko Therapeutics. • The partnership is...

Lilly Inks $1.9B R&D Deal, Eyes Late 2026 China Launch for Oral Obesity Drug

Eli Lilly announced a research and development collaboration with Chinese drug developer Abbisko Therapeutics potentially worth up to $1.9 billion. [6, 8]...